| 0 |
ADAMTS13 INHIBITOR SCREEN ASSAY |
3 |
1.0000 |
| 1 |
ADAMTS13 ACTIVITY ASSAY |
1 |
1.0000 |
| 2 |
ADAMTS13 ACTIVITY ABNORMAL |
73 |
0.8022 |
| 3 |
PLACENTAL OEDEMA |
8 |
0.7273 |
| 4 |
ADAMTS13 ACTIVITY DECREASED |
161 |
0.6216 |
| 5 |
ADAMTS13 ACTIVITY INCREASED |
4 |
0.5000 |
| 6 |
HAEMORRHAGIC PANCREATIC CYST |
1 |
0.5000 |
| 7 |
POST TRANSFUSION PURPURA |
2 |
0.2500 |
| 8 |
SPLENIC ARTERY EMBOLISATION |
1 |
0.1429 |
| 9 |
STRESS ULCER HAEMORRHAGE |
1 |
0.1250 |
| 10 |
COMPRESSION GARMENT APPLICATION |
1 |
0.1111 |
| 11 |
RETICULOCYTE PERCENTAGE ABNORMAL |
1 |
0.1000 |
| 12 |
BLOOD GLUCAGON DECREASED |
1 |
0.0833 |
| 13 |
SEPTIC PHLEBITIS |
1 |
0.0769 |
| 14 |
RED BLOOD CELL ANISOCYTES PRESENT |
1 |
0.0714 |
| 15 |
STOMATOCYTES PRESENT |
1 |
0.0714 |
| 16 |
RED BLOOD CELL MICROCYTES PRESENT |
1 |
0.0667 |
| 17 |
TRANSFERRIN SATURATION ABNORMAL |
1 |
0.0588 |
| 18 |
RED BLOOD CELL POIKILOCYTES PRESENT |
1 |
0.0556 |
| 19 |
FACTOR VIII ACTIVITY INCREASED |
1 |
0.0526 |
| 20 |
EMBOLIC CEREBELLAR INFARCTION |
1 |
0.0476 |
| 21 |
MONOCYTE PERCENTAGE ABNORMAL |
1 |
0.0455 |
| 22 |
LYMPHOCYTE PERCENTAGE ABNORMAL |
3 |
0.0435 |
| 23 |
MEDICAL DEVICE SITE PRURITUS |
1 |
0.0370 |
| 24 |
POSTERIOR TIBIAL TENDON DYSFUNCTION |
1 |
0.0357 |
| 25 |
INHIBITING ANTIBODIES |
2 |
0.0286 |
| 26 |
PERIPHERAL VEIN THROMBUS EXTENSION |
1 |
0.0256 |
| 27 |
MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL |
4 |
0.0248 |
| 28 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
84 |
0.0238 |
| 29 |
PROSTATIC DYSPLASIA |
1 |
0.0222 |
| 30 |
HEPATITIS E VIRUS TEST POSITIVE |
1 |
0.0217 |
| 31 |
HAPTOGLOBIN ABNORMAL |
2 |
0.0217 |
| 32 |
RED CELL DISTRIBUTION WIDTH ABNORMAL |
4 |
0.0211 |
| 33 |
CARDIAC PERFUSION DEFECT |
1 |
0.0189 |
| 34 |
RETICULOCYTE COUNT ABNORMAL |
2 |
0.0179 |
| 35 |
HAEMOGLOBINAEMIA |
3 |
0.0175 |
| 36 |
IMMATURE GRANULOCYTE PERCENTAGE INCREASED |
1 |
0.0164 |
| 37 |
BRONCHOALVEOLAR LAVAGE |
1 |
0.0164 |
| 38 |
GRANULOCYTES ABNORMAL |
3 |
0.0149 |
| 39 |
MEAN CELL VOLUME ABNORMAL |
7 |
0.0148 |
| 40 |
EYELID HAEMATOMA |
1 |
0.0147 |
| 41 |
PARVOVIRUS B19 TEST POSITIVE |
1 |
0.0141 |
| 42 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
9 |
0.0133 |
| 43 |
MEAN PLATELET VOLUME ABNORMAL |
1 |
0.0125 |
| 44 |
BLOOD CHLORIDE ABNORMAL |
2 |
0.0123 |
| 45 |
MUCOSAL PAIN |
1 |
0.0119 |
| 46 |
SCHISTOCYTOSIS |
1 |
0.0115 |
| 47 |
PLATELET AGGREGATION |
1 |
0.0114 |
| 48 |
HUMORAL IMMUNE DEFECT |
4 |
0.0108 |
| 49 |
LIP SCAB |
1 |
0.0103 |
| 50 |
ORAL BLOOD BLISTER |
2 |
0.0100 |
| 51 |
SIGNET-RING CELL CARCINOMA |
1 |
0.0100 |
| 52 |
BLEEDING TIME ABNORMAL |
1 |
0.0097 |
| 53 |
INJECTION SITE PLAQUE |
2 |
0.0095 |
| 54 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
3 |
0.0093 |
| 55 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
3 |
0.0090 |
| 56 |
PARANASAL SINUS HAEMORRHAGE |
1 |
0.0090 |
| 57 |
NUCLEATED RED CELLS |
1 |
0.0089 |
| 58 |
PLATELET COUNT ABNORMAL |
47 |
0.0078 |
| 59 |
PREMENSTRUAL PAIN |
1 |
0.0076 |
| 60 |
PLACENTAL INSUFFICIENCY |
6 |
0.0075 |
| 61 |
GENITAL INJURY |
1 |
0.0075 |
| 62 |
HAEMATOCRIT ABNORMAL |
9 |
0.0073 |
| 63 |
ALBUMIN GLOBULIN RATIO INCREASED |
1 |
0.0073 |
| 64 |
INJECTION SITE DERMATITIS |
1 |
0.0069 |
| 65 |
HAIR GROWTH RATE ABNORMAL |
1 |
0.0068 |
| 66 |
MUSCLE TONE DISORDER |
2 |
0.0064 |
| 67 |
CARBON DIOXIDE ABNORMAL |
2 |
0.0064 |
| 68 |
RED BLOOD CELL COUNT ABNORMAL |
9 |
0.0061 |
| 69 |
INTESTINAL GANGRENE |
1 |
0.0059 |
| 70 |
MULTISYSTEM INFLAMMATORY SYNDROME |
1 |
0.0058 |
| 71 |
BENIGN RENAL NEOPLASM |
1 |
0.0058 |
| 72 |
ABNORMAL MENSTRUAL CLOTS |
1 |
0.0057 |
| 73 |
INJECTION SITE EROSION |
2 |
0.0057 |
| 74 |
SUBCHORIONIC HAEMATOMA |
1 |
0.0057 |
| 75 |
COMPLEMENT FACTOR DECREASED |
1 |
0.0056 |
| 76 |
TRANCE |
2 |
0.0055 |
| 77 |
AEROMONAS INFECTION |
1 |
0.0053 |
| 78 |
HAEMOFILTRATION |
1 |
0.0053 |
| 79 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
2 |
0.0053 |
| 80 |
OPHTHALMIC HERPES SIMPLEX |
3 |
0.0052 |
| 81 |
ACINETOBACTER TEST POSITIVE |
1 |
0.0052 |
| 82 |
STENT REMOVAL |
1 |
0.0051 |
| 83 |
EOSINOPHIL PERCENTAGE DECREASED |
1 |
0.0050 |
| 84 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
3 |
0.0050 |
| 85 |
CATHETER SITE HAEMORRHAGE |
12 |
0.0048 |
| 86 |
SUBCAPSULAR RENAL HAEMATOMA |
1 |
0.0047 |
| 87 |
ROCKY MOUNTAIN SPOTTED FEVER |
1 |
0.0047 |
| 88 |
THROMBOLYSIS |
1 |
0.0045 |
| 89 |
MONOCYTE COUNT ABNORMAL |
1 |
0.0045 |
| 90 |
MUCOSAL HAEMORRHAGE |
5 |
0.0043 |
| 91 |
CENTRAL VENOUS CATHETER REMOVAL |
2 |
0.0043 |
| 92 |
ENTEROBACTER TEST POSITIVE |
1 |
0.0041 |
| 93 |
SERRATIA INFECTION |
3 |
0.0040 |
| 94 |
STEROID DIABETES |
6 |
0.0040 |
| 95 |
CHRONIC DISEASE |
1 |
0.0039 |
| 96 |
LACK OF SATIETY |
1 |
0.0038 |
| 97 |
IMMUNOGLOBULINS ABNORMAL |
1 |
0.0038 |
| 98 |
HAPTOGLOBIN DECREASED |
3 |
0.0037 |
| 99 |
RETICULOCYTE COUNT INCREASED |
3 |
0.0037 |
| 100 |
CATHETER SITE THROMBOSIS |
1 |
0.0036 |
| 101 |
NEUROLOGIC NEGLECT SYNDROME |
2 |
0.0036 |
| 102 |
PLATELET DYSFUNCTION |
1 |
0.0036 |
| 103 |
GINGIVAL BLEEDING |
49 |
0.0036 |
| 104 |
MEAN PLATELET VOLUME DECREASED |
3 |
0.0036 |
| 105 |
IMMATURE GRANULOCYTE COUNT INCREASED |
1 |
0.0035 |
| 106 |
MEDICAL DEVICE SITE HAEMORRHAGE |
1 |
0.0035 |
| 107 |
BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED |
1 |
0.0034 |
| 108 |
CATHETER SITE HAEMATOMA |
1 |
0.0034 |
| 109 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
7 |
0.0034 |
| 110 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
3 |
0.0034 |
| 111 |
POLYCHROMASIA |
1 |
0.0033 |
| 112 |
HYDROPS FOETALIS |
2 |
0.0033 |
| 113 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
1 |
0.0032 |
| 114 |
BRONCHIAL HAEMORRHAGE |
1 |
0.0032 |
| 115 |
PLATELET COUNT INCREASED |
41 |
0.0031 |
| 116 |
INJECTION SITE SCAB |
3 |
0.0031 |
| 117 |
CATHETER SITE BRUISE |
1 |
0.0030 |
| 118 |
SERUM SICKNESS |
8 |
0.0029 |
| 119 |
CATHETER REMOVAL |
1 |
0.0028 |
| 120 |
PLASMABLASTIC LYMPHOMA |
1 |
0.0028 |
| 121 |
ANTIBODY TEST ABNORMAL |
2 |
0.0028 |
| 122 |
CEREBRAL MASS EFFECT |
1 |
0.0028 |
| 123 |
OLIGOHYDRAMNIOS |
9 |
0.0027 |
| 124 |
GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC |
1 |
0.0027 |
| 125 |
TRAUMATIC HAEMORRHAGE |
5 |
0.0027 |
| 126 |
HEAVY MENSTRUAL BLEEDING |
23 |
0.0026 |
| 127 |
PREGNANCY TEST POSITIVE |
1 |
0.0025 |
| 128 |
PRODUCT USE IN UNAPPROVED INDICATION |
619 |
0.0025 |
| 129 |
BLEEDING TIME PROLONGED |
3 |
0.0025 |
| 130 |
CRANIOTOMY |
1 |
0.0024 |
| 131 |
GASTROENTERITIS SALMONELLA |
2 |
0.0024 |
| 132 |
FOETAL DISTRESS SYNDROME |
5 |
0.0024 |
| 133 |
LIP HAEMORRHAGE |
3 |
0.0024 |
| 134 |
FRONTOTEMPORAL DEMENTIA |
1 |
0.0023 |
| 135 |
HAEMOGLOBIN ABNORMAL |
15 |
0.0023 |
| 136 |
SYSTOLIC HYPERTENSION |
1 |
0.0023 |
| 137 |
CEREBRAL MICROHAEMORRHAGE |
1 |
0.0022 |
| 138 |
BLOOD UREA ABNORMAL |
2 |
0.0021 |
| 139 |
AIR EMBOLISM |
1 |
0.0021 |
| 140 |
HYPERMETROPIA |
2 |
0.0021 |
| 141 |
BLOOD IRON ABNORMAL |
2 |
0.0020 |
| 142 |
HYPERCREATININAEMIA |
1 |
0.0020 |
| 143 |
SPLENIC VEIN THROMBOSIS |
1 |
0.0020 |
| 144 |
BLOOD ALBUMIN ABNORMAL |
1 |
0.0019 |
| 145 |
PLASMAPHERESIS |
1 |
0.0019 |
| 146 |
ABDOMINAL INJURY |
1 |
0.0019 |
| 147 |
HAEMORRHAGIC INFARCTION |
1 |
0.0018 |
| 148 |
MEAN CELL HAEMOGLOBIN INCREASED |
3 |
0.0018 |
| 149 |
CARDIOSPASM |
1 |
0.0018 |
| 150 |
EPISTAXIS |
133 |
0.0018 |
| 151 |
ENCEPHALOMALACIA |
1 |
0.0018 |
| 152 |
NAIL BED BLEEDING |
1 |
0.0018 |
| 153 |
PHLEBITIS |
9 |
0.0018 |
| 154 |
SPLENECTOMY |
2 |
0.0017 |
| 155 |
TRANSAMINASES ABNORMAL |
1 |
0.0017 |
| 156 |
OSTEOGENESIS IMPERFECTA |
1 |
0.0017 |
| 157 |
THALAMIC INFARCTION |
1 |
0.0017 |
| 158 |
MULTIMORBIDITY |
2 |
0.0017 |
| 159 |
FOETAL GROWTH RESTRICTION |
10 |
0.0016 |
| 160 |
PRODUCT USED FOR UNKNOWN INDICATION |
2 |
0.0016 |
| 161 |
NEUTROPHIL PERCENTAGE INCREASED |
2 |
0.0016 |
| 162 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
25 |
0.0016 |
| 163 |
SUBCUTANEOUS HAEMATOMA |
2 |
0.0016 |
| 164 |
MEAN CELL VOLUME INCREASED |
4 |
0.0016 |
| 165 |
PNEUMONIA NECROTISING |
1 |
0.0015 |
| 166 |
IMMUNE THROMBOCYTOPENIA |
7 |
0.0015 |
| 167 |
PNEUMOCOCCAL SEPSIS |
1 |
0.0015 |
| 168 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
1 |
0.0015 |
| 169 |
GINGIVAL DISCOMFORT |
1 |
0.0015 |
| 170 |
LYMPHOCYTE PERCENTAGE DECREASED |
2 |
0.0015 |
| 171 |
SMALL INTESTINAL HAEMORRHAGE |
3 |
0.0015 |
| 172 |
PARANEOPLASTIC SYNDROME |
1 |
0.0015 |
| 173 |
THROMBOCYTOPENIC PURPURA |
2 |
0.0015 |
| 174 |
PERIPHERAL ARTERY THROMBOSIS |
2 |
0.0014 |
| 175 |
SUTURE RELATED COMPLICATION |
1 |
0.0014 |
| 176 |
NEUTROPHIL COUNT ABNORMAL |
4 |
0.0014 |
| 177 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 178 |
WHITE BLOOD CELL COUNT ABNORMAL |
9 |
0.0014 |
| 179 |
INFUSION SITE BRUISING |
3 |
0.0014 |
| 180 |
BACTERIAL DISEASE CARRIER |
1 |
0.0014 |
| 181 |
HEMIANOPIA HOMONYMOUS |
1 |
0.0014 |
| 182 |
THROMBOCYTOSIS |
5 |
0.0014 |
| 183 |
SPONTANEOUS HAEMATOMA |
1 |
0.0013 |
| 184 |
GINGIVAL ULCERATION |
1 |
0.0013 |
| 185 |
TRACHEITIS |
1 |
0.0013 |
| 186 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
2 |
0.0013 |
| 187 |
ASPIRATION PLEURAL CAVITY |
1 |
0.0013 |
| 188 |
PANCREATIC PSEUDOCYST |
1 |
0.0013 |
| 189 |
CRITICAL ILLNESS |
1 |
0.0013 |
| 190 |
INFECTION PARASITIC |
1 |
0.0013 |
| 191 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 192 |
PRE-ECLAMPSIA |
6 |
0.0013 |
| 193 |
HAEMOPERITONEUM |
1 |
0.0012 |
| 194 |
PLATELET COUNT DECREASED |
133 |
0.0012 |
| 195 |
SHOULDER FRACTURE |
2 |
0.0012 |
| 196 |
ANTIBODY TEST POSITIVE |
2 |
0.0012 |
| 197 |
RED CELL DISTRIBUTION WIDTH INCREASED |
5 |
0.0012 |
| 198 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
2 |
0.0012 |
| 199 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 200 |
POST PROCEDURAL HAEMATOMA |
2 |
0.0012 |
| 201 |
INJECTION SITE COLDNESS |
1 |
0.0012 |
| 202 |
VITAL FUNCTIONS ABNORMAL |
1 |
0.0012 |
| 203 |
ATONIC SEIZURES |
1 |
0.0012 |
| 204 |
VASOCONSTRICTION |
1 |
0.0011 |
| 205 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 206 |
TERMINAL INSOMNIA |
2 |
0.0011 |
| 207 |
FIBRIN D DIMER INCREASED |
4 |
0.0011 |
| 208 |
BLOOD ALBUMIN INCREASED |
1 |
0.0011 |
| 209 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 210 |
INJECTION SITE DRYNESS |
1 |
0.0011 |
| 211 |
INTESTINAL INFARCTION |
1 |
0.0011 |
| 212 |
MEAN CELL HAEMOGLOBIN DECREASED |
2 |
0.0011 |
| 213 |
FOETAL HEART RATE ABNORMAL |
1 |
0.0011 |
| 214 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 215 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 216 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 217 |
TROPONIN INCREASED |
8 |
0.0011 |
| 218 |
VAGINAL DISORDER |
1 |
0.0010 |
| 219 |
RED BLOOD CELL ABNORMALITY |
1 |
0.0010 |
| 220 |
DISCOLOURED VOMIT |
1 |
0.0010 |
| 221 |
BLOOD URINE |
1 |
0.0010 |
| 222 |
APPLICATION SITE BRUISE |
1 |
0.0010 |
| 223 |
ABDOMINAL WALL HAEMATOMA |
2 |
0.0010 |
| 224 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
5 |
0.0010 |
| 225 |
CARDIAC ANEURYSM |
1 |
0.0010 |
| 226 |
HIGH DENSITY LIPOPROTEIN INCREASED |
1 |
0.0010 |
| 227 |
BRAIN HYPOXIA |
1 |
0.0010 |
| 228 |
EMBOLISM VENOUS |
3 |
0.0010 |
| 229 |
GASTRIC PH DECREASED |
1 |
0.0010 |
| 230 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 231 |
FOETAL DEATH |
5 |
0.0010 |
| 232 |
MOUTH HAEMORRHAGE |
7 |
0.0010 |
| 233 |
CARPAL TUNNEL DECOMPRESSION |
1 |
0.0009 |
| 234 |
CEREBRAL ARTERY OCCLUSION |
1 |
0.0009 |
| 235 |
FOOD POISONING |
5 |
0.0009 |
| 236 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
16 |
0.0009 |
| 237 |
LYMPHOCYTOSIS |
2 |
0.0009 |
| 238 |
SOMATIC SYMPTOM DISORDER |
1 |
0.0009 |
| 239 |
CONTUSION |
89 |
0.0009 |
| 240 |
INFUSION SITE HAEMORRHAGE |
3 |
0.0009 |
| 241 |
EPSTEIN-BARR VIRAEMIA |
1 |
0.0009 |
| 242 |
INTERMENSTRUAL BLEEDING |
5 |
0.0009 |
| 243 |
PULMONARY ALVEOLAR HAEMORRHAGE |
5 |
0.0009 |
| 244 |
LYMPHOCYTE COUNT ABNORMAL |
1 |
0.0009 |
| 245 |
INJECTION SITE BRUISING |
70 |
0.0009 |
| 246 |
ARTERIAL HAEMORRHAGE |
1 |
0.0009 |
| 247 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 248 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 249 |
AORTIC THROMBOSIS |
1 |
0.0009 |
| 250 |
PETECHIAE |
9 |
0.0009 |
| 251 |
RECTAL ULCER |
1 |
0.0009 |
| 252 |
ISCHAEMIC STROKE |
15 |
0.0008 |
| 253 |
FULL BLOOD COUNT INCREASED |
1 |
0.0008 |
| 254 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 255 |
LACUNAR INFARCTION |
2 |
0.0008 |
| 256 |
HAEMATOCRIT DECREASED |
16 |
0.0008 |
| 257 |
ABDOMINAL TENDERNESS |
4 |
0.0008 |
| 258 |
CONJUNCTIVAL HAEMORRHAGE |
3 |
0.0008 |
| 259 |
HAEMOLYTIC ANAEMIA |
7 |
0.0008 |
| 260 |
ORGAN FAILURE |
3 |
0.0007 |
| 261 |
SUBDURAL HAEMORRHAGE |
2 |
0.0007 |
| 262 |
ABSCESS ORAL |
1 |
0.0007 |
| 263 |
CORNEAL ABRASION |
1 |
0.0007 |
| 264 |
RED BLOOD CELL COUNT INCREASED |
2 |
0.0007 |
| 265 |
NASAL DISCHARGE DISCOLOURATION |
1 |
0.0007 |
| 266 |
DISCHARGE |
1 |
0.0007 |
| 267 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 268 |
ANAL HAEMORRHAGE |
2 |
0.0007 |
| 269 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 270 |
ALVEOLITIS |
1 |
0.0007 |
| 271 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 272 |
TRACHEOSTOMY |
1 |
0.0007 |
| 273 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 274 |
RENAL INFARCT |
1 |
0.0007 |
| 275 |
FINE MOTOR SKILL DYSFUNCTION |
2 |
0.0007 |
| 276 |
NONINFECTIVE GINGIVITIS |
1 |
0.0007 |
| 277 |
FAT TISSUE INCREASED |
1 |
0.0007 |
| 278 |
BRAIN HERNIATION |
2 |
0.0007 |
| 279 |
MYOCLONIC EPILEPSY |
1 |
0.0007 |
| 280 |
MOUTH INJURY |
1 |
0.0007 |
| 281 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0007 |
| 282 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 283 |
COITAL BLEEDING |
1 |
0.0006 |
| 284 |
INJECTION SITE HYPERSENSITIVITY |
2 |
0.0006 |
| 285 |
SKIN ABRASION |
3 |
0.0006 |
| 286 |
INTERMITTENT CLAUDICATION |
1 |
0.0006 |
| 287 |
GINGIVAL PAIN |
5 |
0.0006 |
| 288 |
CUSHINGOID |
2 |
0.0006 |
| 289 |
INCOHERENT |
4 |
0.0006 |
| 290 |
THROMBOTIC MICROANGIOPATHY |
6 |
0.0006 |
| 291 |
SHOCK HAEMORRHAGIC |
5 |
0.0006 |
| 292 |
BRADYPHRENIA |
4 |
0.0006 |
| 293 |
VASOPLEGIA SYNDROME |
1 |
0.0006 |
| 294 |
PRODUCT PREPARATION ISSUE |
4 |
0.0006 |
| 295 |
SUSPECTED COVID-19 |
2 |
0.0006 |
| 296 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 297 |
ARTHROPOD STING |
1 |
0.0006 |
| 298 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 299 |
CEREBELLAR INFARCTION |
1 |
0.0006 |
| 300 |
SPLEEN DISORDER |
1 |
0.0006 |
| 301 |
INJECTION SITE RASH |
18 |
0.0006 |
| 302 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 303 |
MILIARIA |
1 |
0.0006 |
| 304 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 305 |
BLOOD CREATININE ABNORMAL |
2 |
0.0006 |
| 306 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 307 |
OTORRHOEA |
1 |
0.0006 |
| 308 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 309 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 310 |
HAEMORRHAGIC DIATHESIS |
2 |
0.0006 |
| 311 |
INTERCEPTED PRODUCT STORAGE ERROR |
2 |
0.0006 |
| 312 |
INJECTION SITE DISCOLOURATION |
7 |
0.0006 |
| 313 |
MONOCYTE COUNT INCREASED |
2 |
0.0006 |
| 314 |
SKIN HAEMORRHAGE |
8 |
0.0005 |
| 315 |
STENOSIS |
1 |
0.0005 |
| 316 |
HAEMOLYSIS |
4 |
0.0005 |
| 317 |
BRONCHOPULMONARY ASPERGILLOSIS |
4 |
0.0005 |
| 318 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 319 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
15 |
0.0005 |
| 320 |
PSYCHIATRIC DECOMPENSATION |
1 |
0.0005 |
| 321 |
WOUND SECRETION |
2 |
0.0005 |
| 322 |
BICYTOPENIA |
1 |
0.0005 |
| 323 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 324 |
LABORATORY TEST ABNORMAL |
15 |
0.0005 |
| 325 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 326 |
HYPERPHAGIA |
2 |
0.0005 |
| 327 |
EAR HAEMORRHAGE |
1 |
0.0005 |
| 328 |
BODY TEMPERATURE INCREASED |
10 |
0.0005 |
| 329 |
QUADRIPLEGIA |
1 |
0.0005 |
| 330 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 331 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 332 |
DISEASE RECURRENCE |
23 |
0.0005 |
| 333 |
MENSTRUAL DISORDER |
4 |
0.0005 |
| 334 |
NASAL DRYNESS |
3 |
0.0005 |
| 335 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 336 |
INJECTION SITE IRRITATION |
6 |
0.0005 |
| 337 |
CHAPPED LIPS |
2 |
0.0005 |
| 338 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 339 |
HAEMORRHAGE |
48 |
0.0005 |
| 340 |
HAEMOGLOBIN DECREASED |
47 |
0.0005 |
| 341 |
PURPURA |
4 |
0.0005 |
| 342 |
POSTOPERATIVE WOUND INFECTION |
3 |
0.0004 |
| 343 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 344 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 345 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 346 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 347 |
PERFORMANCE STATUS DECREASED |
2 |
0.0004 |
| 348 |
DISCOURAGEMENT |
1 |
0.0004 |
| 349 |
PUSTULE |
1 |
0.0004 |
| 350 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 351 |
SUBDURAL HAEMATOMA |
6 |
0.0004 |
| 352 |
CEREBRAL HAEMORRHAGE |
15 |
0.0004 |
| 353 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
9 |
0.0004 |
| 354 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 355 |
DERMAL CYST |
1 |
0.0004 |
| 356 |
GASTROINTESTINAL HAEMORRHAGE |
34 |
0.0004 |
| 357 |
INTRAVENTRICULAR HAEMORRHAGE |
1 |
0.0004 |
| 358 |
INJECTION SITE INFLAMMATION |
2 |
0.0004 |
| 359 |
HAEMORRHAGE INTRACRANIAL |
6 |
0.0004 |
| 360 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
4 |
0.0004 |
| 361 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 362 |
PLATELET DISORDER |
1 |
0.0004 |
| 363 |
HAEMOPTYSIS |
11 |
0.0004 |
| 364 |
SUBARACHNOID HAEMORRHAGE |
4 |
0.0004 |
| 365 |
VAGINAL HAEMORRHAGE |
17 |
0.0004 |
| 366 |
NEUTROPHIL COUNT INCREASED |
4 |
0.0004 |
| 367 |
INJECTION SITE HAEMORRHAGE |
31 |
0.0004 |
| 368 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 369 |
HAEMATOMA |
10 |
0.0004 |
| 370 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 371 |
PULMONARY HAEMORRHAGE |
3 |
0.0004 |
| 372 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 373 |
URINE OUTPUT INCREASED |
1 |
0.0004 |
| 374 |
TRANSFUSION |
4 |
0.0004 |
| 375 |
POOR QUALITY PRODUCT ADMINISTERED |
4 |
0.0004 |
| 376 |
LUNG OPACITY |
1 |
0.0004 |
| 377 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 378 |
STEATORRHOEA |
1 |
0.0004 |
| 379 |
RECTAL HAEMORRHAGE |
16 |
0.0004 |
| 380 |
LARYNGOSPASM |
1 |
0.0004 |
| 381 |
GASTROINTESTINAL INJURY |
1 |
0.0004 |
| 382 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 383 |
MOOD ALTERED |
10 |
0.0004 |
| 384 |
HEMIPLEGIA |
3 |
0.0004 |
| 385 |
HAEMORRHOIDS |
7 |
0.0004 |
| 386 |
HEART RATE ABNORMAL |
2 |
0.0004 |
| 387 |
INJECTION SITE PRURITUS |
24 |
0.0004 |
| 388 |
HAEMATEMESIS |
9 |
0.0004 |
| 389 |
REBOUND EFFECT |
4 |
0.0004 |
| 390 |
DIALYSIS |
5 |
0.0004 |
| 391 |
INTERNAL HAEMORRHAGE |
4 |
0.0003 |
| 392 |
RED BLOOD CELL COUNT DECREASED |
10 |
0.0003 |
| 393 |
POST PROCEDURAL HAEMORRHAGE |
4 |
0.0003 |
| 394 |
URINE ODOUR ABNORMAL |
2 |
0.0003 |
| 395 |
GROWTH RETARDATION |
1 |
0.0003 |
| 396 |
DEEP VEIN THROMBOSIS |
22 |
0.0003 |
| 397 |
BACTERAEMIA |
4 |
0.0003 |
| 398 |
THROMBOSIS |
27 |
0.0003 |
| 399 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 400 |
HYPERCAPNIA |
1 |
0.0003 |
| 401 |
HIV INFECTION |
1 |
0.0003 |
| 402 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 403 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 404 |
CEREBRAL INFARCTION |
8 |
0.0003 |
| 405 |
DUODENITIS |
1 |
0.0003 |
| 406 |
INTRACARDIAC THROMBUS |
1 |
0.0003 |
| 407 |
HOSPITALISATION |
50 |
0.0003 |
| 408 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 409 |
FAECES DISCOLOURED |
7 |
0.0003 |
| 410 |
BLOOD BLISTER |
1 |
0.0003 |
| 411 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 412 |
BRAIN OEDEMA |
4 |
0.0003 |
| 413 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
7 |
0.0003 |
| 414 |
BILE DUCT STONE |
1 |
0.0003 |
| 415 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 416 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 417 |
DRUG SPECIFIC ANTIBODY PRESENT |
2 |
0.0003 |
| 418 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 419 |
MENORRHAGIA |
6 |
0.0003 |
| 420 |
PERICARDIAL EFFUSION |
7 |
0.0003 |
| 421 |
ANXIETY DISORDER |
1 |
0.0003 |
| 422 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0003 |
| 423 |
ECCHYMOSIS |
2 |
0.0003 |
| 424 |
WHITE BLOOD CELL COUNT INCREASED |
11 |
0.0003 |
| 425 |
RASH MACULAR |
10 |
0.0003 |
| 426 |
EMBOLIC STROKE |
1 |
0.0003 |
| 427 |
SKIN REACTION |
4 |
0.0003 |
| 428 |
LYMPHOCYTE COUNT DECREASED |
5 |
0.0003 |
| 429 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 430 |
SKIN WEEPING |
1 |
0.0003 |
| 431 |
DECREASED ACTIVITY |
3 |
0.0003 |
| 432 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 433 |
MELAENA |
6 |
0.0003 |
| 434 |
RECTAL DISCHARGE |
1 |
0.0003 |
| 435 |
BLOOD GLUCOSE ABNORMAL |
5 |
0.0003 |
| 436 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0003 |
| 437 |
INJECTION SITE PAIN |
82 |
0.0003 |
| 438 |
CHROMATURIA |
6 |
0.0003 |
| 439 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 440 |
SNORING |
1 |
0.0003 |
| 441 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 442 |
CONDITION AGGRAVATED |
80 |
0.0003 |
| 443 |
MENSTRUATION IRREGULAR |
7 |
0.0003 |
| 444 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 445 |
DEVICE RELATED INFECTION |
4 |
0.0003 |
| 446 |
INJECTION SITE ERYTHEMA |
32 |
0.0003 |
| 447 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 448 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 449 |
NERVOUS SYSTEM DISORDER |
8 |
0.0003 |
| 450 |
HAEMORRHAGIC STROKE |
2 |
0.0003 |
| 451 |
BRAIN FOG |
4 |
0.0003 |
| 452 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 453 |
BLOOD IRON DECREASED |
3 |
0.0003 |
| 454 |
FURUNCLE |
2 |
0.0003 |
| 455 |
NASAL DISCOMFORT |
2 |
0.0003 |
| 456 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 457 |
OBESITY |
4 |
0.0003 |
| 458 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 459 |
BLOOD DISORDER |
2 |
0.0002 |
| 460 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 461 |
VITAMIN B12 DEFICIENCY |
1 |
0.0002 |
| 462 |
INJECTION SITE URTICARIA |
6 |
0.0002 |
| 463 |
GOITRE |
1 |
0.0002 |
| 464 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 465 |
INJECTION SITE EXTRAVASATION |
3 |
0.0002 |
| 466 |
HAEMODIALYSIS |
2 |
0.0002 |
| 467 |
OFF LABEL USE |
208 |
0.0002 |
| 468 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
13 |
0.0002 |
| 469 |
HEMIPARESIS |
4 |
0.0002 |
| 470 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 471 |
HAEMATOCHEZIA |
13 |
0.0002 |
| 472 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
4 |
0.0002 |
| 473 |
HEPATIC PAIN |
1 |
0.0002 |
| 474 |
VITAMIN D DECREASED |
2 |
0.0002 |
| 475 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 476 |
BLOOD POTASSIUM DECREASED |
7 |
0.0002 |
| 477 |
SKIN SWELLING |
2 |
0.0002 |
| 478 |
NEUROTOXICITY |
4 |
0.0002 |
| 479 |
ORAL CANDIDIASIS |
3 |
0.0002 |
| 480 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 481 |
LYMPHADENOPATHY |
8 |
0.0002 |
| 482 |
UNEVALUABLE EVENT |
17 |
0.0002 |
| 483 |
THROMBOCYTOPENIA |
25 |
0.0002 |
| 484 |
IRON DEFICIENCY |
1 |
0.0002 |
| 485 |
URINARY TRACT DISORDER |
1 |
0.0002 |
| 486 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 487 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 488 |
EAR DISORDER |
1 |
0.0002 |
| 489 |
ISCHAEMIA |
1 |
0.0002 |
| 490 |
HUNGER |
3 |
0.0002 |
| 491 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
1 |
0.0002 |
| 492 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 493 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 494 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 495 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 496 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 497 |
STILLBIRTH |
1 |
0.0002 |
| 498 |
LIVER FUNCTION TEST ABNORMAL |
6 |
0.0002 |
| 499 |
HAEMATURIA |
7 |
0.0002 |
| 500 |
PANCREATIC DISORDER |
1 |
0.0002 |
| 501 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0002 |
| 502 |
VEIN DISORDER |
1 |
0.0002 |
| 503 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 504 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 505 |
TASTE DISORDER |
4 |
0.0002 |
| 506 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 507 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 508 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 509 |
POLLAKIURIA |
8 |
0.0002 |
| 510 |
SCRATCH |
2 |
0.0002 |
| 511 |
SENSORY DISTURBANCE |
3 |
0.0002 |
| 512 |
ANAL FISSURE |
1 |
0.0002 |
| 513 |
THROAT TIGHTNESS |
5 |
0.0002 |
| 514 |
SEPTIC SHOCK |
8 |
0.0002 |
| 515 |
PALLOR |
5 |
0.0002 |
| 516 |
ASTHENOPIA |
1 |
0.0002 |
| 517 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 518 |
NECROSIS |
1 |
0.0002 |
| 519 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 520 |
ANGIOPATHY |
1 |
0.0002 |
| 521 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 522 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 523 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 524 |
METRORRHAGIA |
3 |
0.0002 |
| 525 |
SCAB |
2 |
0.0002 |
| 526 |
CORONARY ARTERY BYPASS |
1 |
0.0002 |
| 527 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 528 |
SKIN WARM |
1 |
0.0002 |
| 529 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 530 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 531 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 532 |
BRADYKINESIA |
1 |
0.0002 |
| 533 |
MATERNAL EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 534 |
THIRST |
3 |
0.0002 |
| 535 |
CHOLECYSTITIS |
2 |
0.0002 |
| 536 |
MYOCLONUS |
2 |
0.0002 |
| 537 |
HEPATITIS B |
1 |
0.0002 |
| 538 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 539 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 540 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0002 |
| 541 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 542 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 543 |
AGEUSIA |
4 |
0.0002 |
| 544 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 545 |
PHOTOPHOBIA |
3 |
0.0002 |
| 546 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 547 |
CARDIAC ARREST |
13 |
0.0002 |
| 548 |
FEELING JITTERY |
3 |
0.0002 |
| 549 |
INCREASED APPETITE |
3 |
0.0002 |
| 550 |
SCREAMING |
1 |
0.0002 |
| 551 |
MOOD SWINGS |
5 |
0.0002 |
| 552 |
RENAL IMPAIRMENT |
13 |
0.0002 |
| 553 |
HERPES SIMPLEX |
1 |
0.0002 |
| 554 |
ORAL HERPES |
3 |
0.0002 |
| 555 |
SKIN DISCOLOURATION |
7 |
0.0002 |
| 556 |
SKIN MASS |
1 |
0.0001 |
| 557 |
SPINAL FRACTURE |
3 |
0.0001 |
| 558 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 559 |
RASH PRURITIC |
8 |
0.0001 |
| 560 |
LIMB INJURY |
4 |
0.0001 |
| 561 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 562 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 563 |
ACNE |
11 |
0.0001 |
| 564 |
DROOLING |
1 |
0.0001 |
| 565 |
FORMICATION |
1 |
0.0001 |
| 566 |
FATIGUE |
111 |
0.0001 |
| 567 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 568 |
HEPATOCELLULAR INJURY |
2 |
0.0001 |
| 569 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
5 |
0.0001 |
| 570 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 571 |
FEAR OF INJECTION |
1 |
0.0001 |
| 572 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 573 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 574 |
PANIC REACTION |
1 |
0.0001 |
| 575 |
SWELLING FACE |
9 |
0.0001 |
| 576 |
INJECTION SITE HAEMATOMA |
2 |
0.0001 |
| 577 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 578 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 579 |
DYSSTASIA |
4 |
0.0001 |
| 580 |
PULMONARY EMBOLISM |
13 |
0.0001 |
| 581 |
ORAL DISORDER |
1 |
0.0001 |
| 582 |
SENSITIVE SKIN |
1 |
0.0001 |
| 583 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 584 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 585 |
HEPATOTOXICITY |
3 |
0.0001 |
| 586 |
ORAL PAIN |
3 |
0.0001 |
| 587 |
RASH PAPULAR |
3 |
0.0001 |
| 588 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 589 |
HEADACHE |
83 |
0.0001 |
| 590 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 591 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 592 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 593 |
ALANINE AMINOTRANSFERASE INCREASED |
8 |
0.0001 |
| 594 |
THYROID DISORDER |
2 |
0.0001 |
| 595 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 596 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 597 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 598 |
INTENTIONAL PRODUCT USE ISSUE |
11 |
0.0001 |
| 599 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 600 |
SENSORY LOSS |
1 |
0.0001 |
| 601 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 602 |
MYALGIA |
21 |
0.0001 |
| 603 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 604 |
FOETAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 605 |
ASPHYXIA |
1 |
0.0001 |
| 606 |
SEIZURE |
14 |
0.0001 |
| 607 |
PARAESTHESIA |
19 |
0.0001 |
| 608 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 609 |
EMBOLISM |
1 |
0.0001 |
| 610 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 611 |
MUSCLE SPASMS |
22 |
0.0001 |
| 612 |
CANDIDA INFECTION |
2 |
0.0001 |
| 613 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 614 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 615 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
3 |
0.0001 |
| 616 |
CARDIAC OPERATION |
1 |
0.0001 |
| 617 |
JOINT SWELLING |
14 |
0.0001 |
| 618 |
MYOPATHY |
1 |
0.0001 |
| 619 |
PYELONEPHRITIS |
1 |
0.0001 |
| 620 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 621 |
FACIAL PAIN |
1 |
0.0001 |
| 622 |
HAEMARTHROSIS |
1 |
0.0001 |
| 623 |
THERAPY NON-RESPONDER |
5 |
0.0001 |
| 624 |
OSTEOMYELITIS |
2 |
0.0001 |
| 625 |
ANAEMIA |
21 |
0.0001 |
| 626 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 627 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 628 |
OVARIAN CANCER |
1 |
0.0001 |
| 629 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 630 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 631 |
FEELING COLD |
3 |
0.0001 |
| 632 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 633 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 634 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 635 |
NEPHROPATHY |
1 |
0.0001 |
| 636 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 637 |
CEREBROVASCULAR ACCIDENT |
18 |
0.0001 |
| 638 |
HOT FLUSH |
8 |
0.0001 |
| 639 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 640 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 641 |
GASTRIC ULCER |
2 |
0.0001 |
| 642 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 643 |
EYE INFLAMMATION |
1 |
0.0001 |
| 644 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 645 |
CHOLESTASIS |
2 |
0.0001 |
| 646 |
AFFECT LABILITY |
1 |
0.0001 |
| 647 |
INFECTION |
15 |
0.0001 |
| 648 |
ARTHRALGIA |
43 |
0.0001 |
| 649 |
PRODUCT STORAGE ERROR |
9 |
0.0001 |
| 650 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 651 |
INJECTION SITE REACTION |
7 |
0.0001 |
| 652 |
HOSPICE CARE |
1 |
0.0001 |
| 653 |
SINUS DISORDER |
2 |
0.0001 |
| 654 |
OVARIAN CYST |
1 |
0.0001 |
| 655 |
PREGNANCY |
2 |
0.0001 |
| 656 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 657 |
THERAPEUTIC RESPONSE DECREASED |
6 |
0.0001 |
| 658 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
20 |
0.0001 |
| 659 |
ASTHENIA |
37 |
0.0001 |
| 660 |
INSOMNIA |
26 |
0.0001 |
| 661 |
PERIPHERAL SWELLING |
15 |
0.0001 |
| 662 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 663 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 664 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 665 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 666 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 667 |
TENDERNESS |
1 |
0.0001 |
| 668 |
ABDOMINAL DISTENSION |
10 |
0.0001 |
| 669 |
SPEECH DISORDER |
5 |
0.0001 |
| 670 |
PYREXIA |
33 |
0.0001 |
| 671 |
PRODUCT DOSE OMISSION ISSUE |
28 |
0.0001 |
| 672 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 673 |
MOUTH ULCERATION |
2 |
0.0001 |
| 674 |
JOINT DISLOCATION |
1 |
0.0001 |
| 675 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 676 |
RENAL PAIN |
1 |
0.0001 |
| 677 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 678 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 679 |
NIGHT SWEATS |
3 |
0.0001 |
| 680 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 681 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 682 |
PRODUCT DOSE OMISSION |
6 |
0.0001 |
| 683 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 684 |
ASPIRATION |
1 |
0.0001 |
| 685 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 686 |
COVID-19 |
16 |
0.0001 |
| 687 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 688 |
HYPERTENSION |
19 |
0.0001 |
| 689 |
RASH |
39 |
0.0001 |
| 690 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 691 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 692 |
ILLNESS |
9 |
0.0001 |
| 693 |
NEOPLASM |
1 |
0.0001 |
| 694 |
BACK PAIN |
20 |
0.0001 |
| 695 |
SWELLING |
8 |
0.0001 |
| 696 |
SPLENOMEGALY |
1 |
0.0001 |
| 697 |
CHILLS |
10 |
0.0001 |
| 698 |
NASAL CONGESTION |
5 |
0.0001 |
| 699 |
BLOOD GLUCOSE INCREASED |
16 |
0.0001 |
| 700 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 701 |
COMA |
4 |
0.0001 |
| 702 |
MOBILITY DECREASED |
6 |
0.0001 |
| 703 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 704 |
IRRITABILITY |
5 |
0.0001 |
| 705 |
LOCALISED INFECTION |
2 |
0.0001 |
| 706 |
FEELING HOT |
5 |
0.0001 |
| 707 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 708 |
ANXIETY |
23 |
0.0001 |
| 709 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 710 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 711 |
DYSARTHRIA |
3 |
0.0001 |
| 712 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 713 |
FEELING ABNORMAL |
19 |
0.0001 |
| 714 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 715 |
CONSTIPATION |
17 |
0.0001 |
| 716 |
MYDRIASIS |
1 |
0.0001 |
| 717 |
GENITAL HAEMORRHAGE |
1 |
0.0001 |
| 718 |
SKIN ULCER |
2 |
0.0001 |
| 719 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 720 |
PALPITATIONS |
9 |
0.0001 |
| 721 |
DEAFNESS |
2 |
0.0001 |
| 722 |
BEDRIDDEN |
1 |
0.0001 |
| 723 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 724 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 725 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 726 |
DISORIENTATION |
3 |
0.0001 |
| 727 |
DEPRESSED MOOD |
4 |
0.0001 |
| 728 |
DYSMENORRHOEA |
1 |
0.0001 |
| 729 |
HYPERSENSITIVITY |
14 |
0.0001 |
| 730 |
ADVERSE REACTION |
1 |
0.0001 |
| 731 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 732 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 733 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 734 |
SINUS CONGESTION |
1 |
0.0001 |
| 735 |
MIGRAINE |
7 |
0.0001 |
| 736 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 737 |
SKIN LESION |
2 |
0.0001 |
| 738 |
TREMOR |
12 |
0.0001 |
| 739 |
INFLUENZA |
8 |
0.0001 |
| 740 |
SEPSIS |
8 |
0.0001 |
| 741 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 742 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 743 |
FLATULENCE |
4 |
0.0001 |
| 744 |
CHEST PAIN |
13 |
0.0001 |
| 745 |
PARALYSIS |
1 |
0.0001 |
| 746 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 747 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 748 |
ANOSMIA |
1 |
0.0001 |
| 749 |
DYSPNOEA |
39 |
0.0001 |
| 750 |
HYPOKINESIA |
1 |
0.0001 |
| 751 |
FLUID OVERLOAD |
1 |
0.0001 |
| 752 |
BONE PAIN |
4 |
0.0001 |
| 753 |
SURGERY |
4 |
0.0001 |
| 754 |
AGITATION |
5 |
0.0001 |
| 755 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 756 |
DISEASE PROGRESSION |
8 |
0.0001 |
| 757 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 758 |
PREMATURE BABY |
2 |
0.0001 |
| 759 |
APHASIA |
2 |
0.0001 |
| 760 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 761 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 762 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 763 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 764 |
OROPHARYNGEAL PAIN |
6 |
0.0001 |
| 765 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 766 |
RENAL DISORDER |
3 |
0.0001 |
| 767 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 768 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 769 |
HEAD INJURY |
2 |
0.0001 |
| 770 |
PNEUMOTHORAX |
1 |
0.0001 |
| 771 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 772 |
ULCER |
1 |
0.0001 |
| 773 |
CYSTITIS |
2 |
0.0001 |
| 774 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 775 |
SCIATICA |
1 |
0.0001 |
| 776 |
HYPERHIDROSIS |
8 |
0.0001 |
| 777 |
RHINORRHOEA |
4 |
0.0001 |
| 778 |
BACK DISORDER |
1 |
0.0001 |
| 779 |
LUNG DISORDER |
3 |
0.0001 |
| 780 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
11 |
0.0001 |
| 781 |
CHOLELITHIASIS |
2 |
0.0001 |
| 782 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 783 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 784 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 785 |
PAIN |
37 |
0.0001 |
| 786 |
FUNGAL INFECTION |
2 |
0.0001 |
| 787 |
GAIT INABILITY |
2 |
0.0001 |
| 788 |
FLUID RETENTION |
3 |
0.0001 |
| 789 |
NEUTROPENIA |
8 |
0.0001 |
| 790 |
PAIN IN EXTREMITY |
17 |
0.0001 |
| 791 |
DELIRIUM |
2 |
0.0001 |
| 792 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 793 |
SYRINGE ISSUE |
1 |
0.0001 |
| 794 |
PANCREATITIS |
3 |
0.0001 |
| 795 |
COLD SWEAT |
1 |
0.0001 |
| 796 |
SLEEP DISORDER |
4 |
0.0001 |
| 797 |
BRADYCARDIA |
3 |
0.0001 |
| 798 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 799 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 800 |
TACHYCARDIA |
5 |
0.0001 |
| 801 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 802 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 803 |
CRYING |
2 |
0.0001 |
| 804 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 805 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 806 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 807 |
URTICARIA |
9 |
0.0001 |
| 808 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 809 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 810 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 811 |
PROTEINURIA |
1 |
0.0001 |
| 812 |
HERPES ZOSTER |
3 |
0.0001 |
| 813 |
PRURITUS |
20 |
0.0001 |
| 814 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 815 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
0.0001 |
| 816 |
EAR PAIN |
1 |
0.0001 |
| 817 |
DYSPHONIA |
3 |
0.0001 |
| 818 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 819 |
DISABILITY |
1 |
0.0001 |
| 820 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 821 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 822 |
NO ADVERSE EVENT |
9 |
0.0000 |
| 823 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 824 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 825 |
DISCOMFORT |
3 |
0.0000 |
| 826 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 827 |
BLINDNESS |
2 |
0.0000 |
| 828 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 829 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 830 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 831 |
EATING DISORDER |
1 |
0.0000 |
| 832 |
RETCHING |
1 |
0.0000 |
| 833 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 834 |
HYPOAESTHESIA |
7 |
0.0000 |
| 835 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 836 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 837 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 838 |
DEHYDRATION |
6 |
0.0000 |
| 839 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 840 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 841 |
ERYTHEMA |
9 |
0.0000 |
| 842 |
SKIN IRRITATION |
2 |
0.0000 |
| 843 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 844 |
HYPOKALAEMIA |
2 |
0.0000 |
| 845 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 846 |
PNEUMONIA |
14 |
0.0000 |
| 847 |
ABDOMINAL PAIN |
10 |
0.0000 |
| 848 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 849 |
COUGH |
12 |
0.0000 |
| 850 |
ARRHYTHMIA |
2 |
0.0000 |
| 851 |
GAIT DISTURBANCE |
8 |
0.0000 |
| 852 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 853 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 854 |
PRESYNCOPE |
1 |
0.0000 |
| 855 |
URINARY TRACT INFECTION |
7 |
0.0000 |
| 856 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 857 |
DYSPEPSIA |
4 |
0.0000 |
| 858 |
HEART RATE INCREASED |
4 |
0.0000 |
| 859 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 860 |
WEIGHT INCREASED |
9 |
0.0000 |
| 861 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 862 |
CELLULITIS |
2 |
0.0000 |
| 863 |
HEPATITIS |
1 |
0.0000 |
| 864 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 865 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 866 |
MALAISE |
17 |
0.0000 |
| 867 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 868 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 869 |
NERVOUSNESS |
2 |
0.0000 |
| 870 |
JOINT STIFFNESS |
1 |
0.0000 |
| 871 |
DIZZINESS |
19 |
0.0000 |
| 872 |
GASTRITIS |
1 |
0.0000 |
| 873 |
EAR INFECTION |
1 |
0.0000 |
| 874 |
CARDIAC FAILURE |
3 |
0.0000 |
| 875 |
PRODUCT USE ISSUE |
7 |
0.0000 |
| 876 |
JAUNDICE |
1 |
0.0000 |
| 877 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 878 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 879 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 880 |
PRODUCT QUALITY ISSUE |
5 |
0.0000 |
| 881 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 882 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 883 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 884 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 885 |
PANCYTOPENIA |
2 |
0.0000 |
| 886 |
BLISTER |
2 |
0.0000 |
| 887 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 888 |
PAIN IN JAW |
1 |
0.0000 |
| 889 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 890 |
INCORRECT DOSE ADMINISTERED |
8 |
0.0000 |
| 891 |
HYPOTENSION |
7 |
0.0000 |
| 892 |
HYPERSOMNIA |
1 |
0.0000 |
| 893 |
BALANCE DISORDER |
3 |
0.0000 |
| 894 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 895 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 896 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 897 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 898 |
HEPATIC FAILURE |
1 |
0.0000 |
| 899 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 900 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 901 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 902 |
EPILEPSY |
1 |
0.0000 |
| 903 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 904 |
CARDIAC DISORDER |
3 |
0.0000 |
| 905 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 906 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 907 |
AMNESIA |
2 |
0.0000 |
| 908 |
IMPAIRED HEALING |
1 |
0.0000 |
| 909 |
OSTEONECROSIS |
1 |
0.0000 |
| 910 |
EYE DISORDER |
1 |
0.0000 |
| 911 |
VIRAL INFECTION |
1 |
0.0000 |
| 912 |
LIP SWELLING |
1 |
0.0000 |
| 913 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 914 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 915 |
VOMITING |
14 |
0.0000 |
| 916 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 917 |
ANGER |
1 |
0.0000 |
| 918 |
FLUSHING |
3 |
0.0000 |
| 919 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 920 |
VISION BLURRED |
4 |
0.0000 |
| 921 |
BURNING SENSATION |
2 |
0.0000 |
| 922 |
HYPERKALAEMIA |
1 |
0.0000 |
| 923 |
HEART RATE DECREASED |
1 |
0.0000 |
| 924 |
INJURY |
2 |
0.0000 |
| 925 |
HYPOXIA |
1 |
0.0000 |
| 926 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 927 |
DYSURIA |
1 |
0.0000 |
| 928 |
INJECTION SITE MASS |
1 |
0.0000 |
| 929 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 930 |
ASTHMA |
3 |
0.0000 |
| 931 |
NAUSEA |
21 |
0.0000 |
| 932 |
DEPRESSION |
6 |
0.0000 |
| 933 |
DIABETES MELLITUS |
2 |
0.0000 |
| 934 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 935 |
DRUG INEFFECTIVE |
33 |
0.0000 |
| 936 |
SOMNOLENCE |
5 |
0.0000 |
| 937 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 938 |
OSTEOPOROSIS |
1 |
0.0000 |
| 939 |
FALL |
8 |
0.0000 |
| 940 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 941 |
TOXICITY TO VARIOUS AGENTS |
4 |
0.0000 |
| 942 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 943 |
DIARRHOEA |
15 |
0.0000 |
| 944 |
MENTAL DISORDER |
1 |
0.0000 |
| 945 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 946 |
DYSPHAGIA |
2 |
0.0000 |
| 947 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 948 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 949 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 950 |
DEATH |
17 |
0.0000 |
| 951 |
SINUSITIS |
2 |
0.0000 |
| 952 |
INFLAMMATION |
1 |
0.0000 |
| 953 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 954 |
ECZEMA |
1 |
0.0000 |
| 955 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 956 |
OEDEMA |
1 |
0.0000 |
| 957 |
MEDICATION ERROR |
1 |
0.0000 |
| 958 |
WEIGHT DECREASED |
5 |
0.0000 |
| 959 |
EYE PAIN |
1 |
0.0000 |
| 960 |
LETHARGY |
1 |
0.0000 |
| 961 |
CATARACT |
1 |
0.0000 |
| 962 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 963 |
VERTIGO |
1 |
0.0000 |
| 964 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 965 |
DRY SKIN |
2 |
0.0000 |
| 966 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 967 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 968 |
BRONCHITIS |
1 |
0.0000 |
| 969 |
DYSGEUSIA |
1 |
0.0000 |
| 970 |
HALLUCINATION |
1 |
0.0000 |
| 971 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 972 |
DECREASED APPETITE |
3 |
0.0000 |
| 973 |
DRY MOUTH |
1 |
0.0000 |
| 974 |
TREATMENT FAILURE |
1 |
0.0000 |
| 975 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 976 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 977 |
DEVICE ISSUE |
1 |
0.0000 |
| 978 |
ADVERSE EVENT |
1 |
0.0000 |
| 979 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 980 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 981 |
ALOPECIA |
2 |
0.0000 |
| 982 |
SYNCOPE |
1 |
0.0000 |
| 983 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 984 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 985 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 986 |
RENAL FAILURE |
1 |
0.0000 |